Cargando…
Pain: A potential new label of COVID-19
Autores principales: | Su, Si, Cui, Huan, Wang, Tao, Shen, Xinhua, Ma, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204693/ https://www.ncbi.nlm.nih.gov/pubmed/32389704 http://dx.doi.org/10.1016/j.bbi.2020.05.025 |
Ejemplares similares
-
Rhabdomyolysis as Potential Late Complication Associated with COVID-19
por: He, Ying-Chao, et al.
Publicado: (2020) -
Potential role of vitamin D in patients with diabetes, dyslipidaemia, and COVID-19
por: Wang, Ming-Ke, et al.
Publicado: (2022) -
Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021) -
Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna
por: Takase, Bonpei, et al.
Publicado: (2021) -
Syringe label: A potential source of dosage error
por: Velayudhan, Savitri, et al.
Publicado: (2014)